Abstract
Nuclear receptor coactivator (NCOA) family gene fusions have been increasingly discovered in diverse mesenchymal neoplasms, while PRRX1-NCOA-fused fibroblastic tumors still remain insufficiently characterized. We herein present two additional PRRX1-NOCA1-positive cases sharing lobulated hypocellular growth of innocuous spindle-to-stellate cells in a fibromyxoid stroma enriched with polymorphous vessels. A constellation of low cellularity, alternating myxocollagenous matrix, bland cytomorphology, and, especially, unusual collagenous rosettes in one case were morphologically reminiscent of low-grade fibromyxoid sarcoma. In both cases, immunoprofiles were similarly nondescript and negative for all diagnostic markers, including MUC4, emphasizing the diagnostic value of molecular testing. Review of published and current cases highlights a striking predominance of PRRX1-NCOA1, unusual collagenous rosettes, and favorable behavior in this emerging fibroblastic tumor type.
References
Lacambra MD et al (2019) PRRX-NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm. Genes Chromosomes Cancer 58(10):705–712
Dermawan JK et al (2021) PRRX1-NCOA1 rearranged fibroblastic tumor: clinicopathologic, immunohistochemical and molecular genetic study of 6 cases of a potentially under-recognized, distinctive mesenchymal tumor. Histopathology. https://doi.org/10.1111/his.14454
Bekers EM et al (2017) Soft tissue angiofibroma: clinicopathologic, immunohistochemical and molecular analysis of 14 cases. Genes Chromosomes Cancer 56(10):750–757
Chen BJ et al (2012) Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications. Am J Surg Pathol 36(8):1119–1128
Puls F et al (2020) Recurrent fusions between YAP1 and KMT2A in morphologically distinct neoplasms within the spectrum of low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma. Am J Surg Pathol 44(5):594–606
Kao YC et al (2020) Recurrent YAP1 and KMT2A gene rearrangements in a subset of MUC4-negative sclerosing epithelioid fibrosarcoma. Am J Surg Pathol 44(3):368–377
Sumegi J et al (2010) Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer 49(3):224–236
Le Loarer F et al (2019) Clinicopathologic and molecular features of a series of 41 biphenotypic sinonasal sarcomas expanding their molecular spectrum. Am J Surg Pathol 43(6):747–754
Wang L et al (2012) Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 51(2):127–139
Agaram NP et al (2019) Expanding the spectrum of intraosseous rhabdomyosarcoma: correlation between 2 distinct gene fusions and phenotype. Am J Surg Pathol 43(5):695–702
Kao YC et al (2021) Recurrent MEIS1-NCOA2/1 fusions in a subset of low-grade spindle cell sarcomas frequently involving the genitourinary and gynecologic tracts. Mod Pathol 34(6):1203–1212
Alaggio R et al (2016) A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related fusions in infantile cases. Am J Surg Pathol 40(2):224–235
Karanian M et al (2020) SRF-FOXO1 and SRF-NCOA1 fusion genes delineate a distinctive subset of well-differentiated rhabdomyosarcoma. Am J Surg Pathol 44(5):607–616
Kobzev YN et al (2004) Analysis of translocations that involve the NUP98 gene in patients with 11p15 chromosomal rearrangements. Genes Chromosomes Cancer 41(4):339–352
Acknowledgements
The authors also thank Kaohsiung Chang Gung genomic (CLRPG8G0591) and tissue bank (CLRPG8F1701 and CLRPG8F1702) core laboratories for technical assistance.
Funding
This work was sponsored in part by the Chang Gung Hospital (CMRPG8L0371 to HYH).
Author information
Authors and Affiliations
Contributions
Chen CH, Chang KC, and Huang HY: conception and design of the work; collection, analysis, and interpretation of the data; drafting the manuscript; and revising it critically for important intellectual content and scientific integrity. Chuang CH and Fu JT: collection, analysis, and interpretation of data and providing the tissue specimens. All authors approve the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
Samples were used in accordance with ethical guidelines for the use of retrospective tissue samples approved by the institutional review board of Chang Gung Memorial Hospital (202002040B0).
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, CH., Chang, KC., Chuang, CH. et al. The emerging PRRX1-NCOA fibroblastic neoplasm: a combined reappraisal of published tumors and two new cases. Virchows Arch 481, 111–116 (2022). https://doi.org/10.1007/s00428-021-03219-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-021-03219-x